Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Ann Surg Oncol. 2023 Oct;30(11):6684-6692. doi: 10.1245/s10434-023-13772-1. Epub 2023 Jun 28.
Segmentectomy has been recommended for peripheral small-sized non-small cell lung cancer (NSCLC). This study aimed to evaluate whether three dimensionally (3D) guided cone-shaped segmentectomy can achieve long-term outcomes comparable with lobectomy for small-sized NSCLC in the middle third of the lung parenchyma.
This study retrospectively screened patients with small NSCLC (≤2 cm) who underwent segmentectomy or lobectomy between January 2012 and June 2019. Tumor location was determined by 3D multiplanar reconstruction. The cone-shaped segmentectomy was performed with the guidance of 3D computed tomographic bronchography and angiography. The log-rank test, Cox hazard proportional regression, and propensity score-matching analyses were adopted for prognostic evaluation.
After screening, 278 patients with segmentectomy and 174 subjects undergoing lobectomy were selected. All the patients had R0 resection, and no 30- or 90-day mortality was observed. The median follow-up time was 47.3 months. The 5-year overall survival (OS) was 99.6 %, and the disease-free survival (DFS) was 97.5 % for the patients undergoing segmentectomy. After propensity score-matching, the patients with segmentectomy (n = 112) had an OS (P = 0.530) and a DFS (P = 0.390) similar to those of the patients who underwent lobectomy (n = 112). The multivariable Cox regression analysis indicated no significant survival differences between segmentectomy and lobectomy [DFS: hazard ratio, 0.56 (95 % confidence interval (CI) 0.16-1.97, P = 0.369); OS: HR, 0.35 (95 % CI 0.06-2.06, P = 0.245)] after adjustment for other factors. Further analysis showed that segmentectomy achieved comparable OS (P = 0.540) and DFS (P = 0.930) for NSCLC in the middle-third and peripheral lung parenchyma (n = 454).
For selected NSCLCs size 2 cm or smaller in the middle third of the lung field, 3D-guided cone-shaped segmentectomy was able to achieve long-term outcomes comparable with lobectomy.
段切除术已被推荐用于外周小型非小细胞肺癌(NSCLC)。本研究旨在评估三维(3D)引导的锥形段切除术是否可实现与中叶小型 NSCLC 肺段切除术相当的长期结果。
本研究回顾性筛选了 2012 年 1 月至 2019 年 6 月期间接受段切除术或肺叶切除术的小 NSCLC(≤2cm)患者。肿瘤位置通过 3D 多平面重建确定。锥形段切除术在 3D 计算机断层支气管造影和血管造影的指导下进行。采用对数秩检验、Cox 风险比例回归和倾向评分匹配分析进行预后评估。
筛选后,278 例患者接受了段切除术,174 例患者接受了肺叶切除术。所有患者均行 R0 切除术,无 30 天或 90 天死亡率。中位随访时间为 47.3 个月。段切除术患者的 5 年总生存率(OS)为 99.6%,无病生存率(DFS)为 97.5%。经过倾向评分匹配后,段切除术组(n=112)的 OS(P=0.530)和 DFS(P=0.390)与肺叶切除术组(n=112)相似。多变量 Cox 回归分析表明,段切除术和肺叶切除术之间无显著生存差异[DFS:风险比,0.56(95%置信区间 0.16-1.97,P=0.369);OS:HR,0.35(95%CI 0.06-2.06,P=0.245)],在调整其他因素后。进一步分析表明,对于中叶和外周肺实质的 2cm 或更小的 NSCLC(n=454),段切除术可实现相当的 OS(P=0.540)和 DFS(P=0.930)。
对于中叶肺段大小为 2cm 或更小的选定 NSCLC,3D 引导的锥形段切除术能够实现与肺叶切除术相当的长期结果。